Bressner JA, McCarthy EF, Fayad LM, et al. Primary rhabdomyosarcoma of the distal femoral diaphysis: a case report and review of the literature[J]. Skeletal Radiol, 2016, 45(10): 1391-1395. doi: 10.1007/s00256-016-2430-7

Dangle PP, Correa A, Tennyson L, et al. Current management of paratesticular rhabdomyosarcoma[J]. Urol Oncol, 2016, 34(2): 84-92. doi: 10.1016/j.urolonc.2015.10.004

Han T, Chen J, Luan Y, et al. Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report[J]. Onco Targets Ther, 2018, 11: 5287-5291. doi: 10.2147/OTT.S170008

Ferrari A, Bisogno G, Casanova M, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group[J]. J Clin Oncol, 2002, 20(2): 449-455. doi: 10.1200/JCO.2002.20.2.449

Chen E, Ricciotti R, Futran N, et al. Head and Neck Rhabdomyosarcoma: Clinical and Pathologic Characterization of Seven Cases[J]. Head Neck Pathol, 2017, 11(3): 321-326. doi: 10.1007/s12105-016-0771-0

Ahmed HU, Arya M, Muneer A, et al. Testicular and paratesticular tumours in the prepubertal population[J]. Lancet Oncol, 2010, 11(5): 476-483. doi: 10.1016/S1470-2045(10)70012-7

Tateishi U, Hosono A, Makimoto A, et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma[J]. Ann Nucl Med, 2009, 23(2): 155-161. doi: 10.1007/s12149-008-0219-z

Eugene T, Corradini N, Carlier T, et al. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas[J]. Nucl Med Commun, 2012, 33(10): 1089-1095. doi: 10.1097/MNM.0b013e328356741f

Wachtel M, Runge T, Leuschner I, et al. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry[J]. J Clin Oncol, 2006, 24(5): 816-822. doi: 10.1200/JCO.2005.03.4934

Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis[J]. Adv Anat Pathol, 2013, 20(6): 387-397. doi: 10.1097/PAP.0b013e3182a92d0d

Cecchetto G, De Corti F, Rogers T, et al. Surgical compliance with guidelines for paratesticular rhabdomyosarcoma(RMS). Data from the European Study on non-metastatic RMS[J]. J Pediatr Surg, 2012, 47(11): 2161-2162. doi: 10.1016/j.jpedsurg.2012.08.004

Dang ND, Dang PT, Samuelian J, et al. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis[J]. Cancer, 2013, 119(17): 3228-3233. doi: 10.1002/cncr.28198

Seitz G, Fuchs J, Martus P, et al. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and-2002P[J]. Ann Surg, 2016, 264(6): 1148-1155 doi: 10.1097/SLA.0000000000001550